Comparative evaluation of effectiveness of diclofenac sodium gel (3%) phonophoresis and piroxicam gel (0.5%) phonophoresis in management of temporomandibular disorders – a single blind, randomized controlled trial.
- Registration Number
- CTRI/2024/02/062681
- Lead Sponsor
- Shruti Saryam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients fulfilling the Diagnostic criteria for temporomandibular disorders
(DC/TMD) for Pain-Related temporomandibular disorders which include
Myalgia (Local myalgia, myofascial pain, and myofascial pain with referral}
and Arthralgia.
2.Recurrent and chronic history of pain
3.Pharmacologic washout of =72 hours for central analgesic, NSAIDS, and
antidepressants.
4.Patients who have given Informed consent.
1.Patients fulfilling the DC/TMD CRITERIA of Diagnostic Procedures for Pain Related temporomandibular disorder which include Headache attributed
to TMD, Disc derangement , Degenerative joint disease, Subluxation.
? Patients on analgesics or anti-inflammatory medication who are not
willing to discontinue
2.Patients on Physiotherapy /complementary and alternative medicine for
the same problem.
3.Patient giving previous history of allergy to diclofenac sodium and
piroxicam drugs.
4.Patients with cardiac pacemakers and implanted defibrillators
5.Patients with jaw Tumors , fractures
6.Systemically compromised patients
7.Pregnant females
8.Patient not willing to give informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method